Lanfang Qin

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

Suleiman Massarweh, C. Kent Osborne, Chad J. Creighton et al. · Cancer Research · 2008 · 494 citations

Medicine, Endocrinology, Pharmacology +17

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 171 citations · Full text

Medicine, Genetics, Oncology +17

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke et al. · Clinical Cancer Research · 2017 · 129 citations · Full text

Medicine, Genetics, Oncology +15

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

Vidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis et al. · Molecular Cancer Research · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16